Study Summary:
An open label study of Cycle Control with Norethindrone Acetate 1mg/Ethinyl Estradiol 20mcg oral tablets administered for 48 days of a 52-day cycle
Qualified Participants Must:
• Be sexually active women
• Be 18-45 years of age
• Have regular menstrual cycles
Qualified Participants May Receive:
-Labs with Complete History
and Physical
-Study Medication
-May recieve Compensation
For Time and Travel